Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $3.5M | $5.7M | $9.3M |
| Cost of revenue | $0 | $291.0K | $613.0K | $1.6M |
| Gross profit | $0 | $3.2M | $5.1M | $7.6M |
| Gross margin | — | 91.8% | 89.3% | 82.5% |
| R&D | $0 | $4.9M | $7.6M | $8.0M |
| Operating income | −$141.0K | −$7.5M | −$10.3M | −$6.2M |
| EBITDA | −$141.0K | −$7.1M | −$9.5M | −$4.4M |
| Net income | −$141.0K | −$10.9M | −$19.3M | −$17.8M |
| Net margin | — | -308.6% | -336.3% | -192.5% |
| EPS (diluted) | -0.00 | -0.44 | -0.50 | -0.27 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds CRBKF.
No tracked institution reports a position in CRBKF as of their last filing.
No one on the platform has traded CRBKF yet.
| $1M |
| — |
| DTXMFDeltex Medical Group plc | $0.10 | +0.00% | $181M | — |
| FFLWFFire & Flower Holdings Corp. | $0.12 | -44.37% | $5M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.